Digital interventions for autism spectrum disorders: A systematic review and meta-analysis

被引:1
|
作者
Wang, Tianqi [1 ]
Ma, Yu [1 ]
Du, Xiaonan [1 ]
Li, Chunpei [1 ]
Peng, Zhongbi [2 ]
Wang, Yi [1 ,4 ]
Zhou, Hao [2 ,3 ,5 ]
机构
[1] Fudan Univ, Childrens Hosp, Natl Childrens Med Ctr, Dept Neurol, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Shanghai Childrens Med Ctr, Sch Med, Dept Neurol Rehabil,Guizhou Branch, Guiyang, Guizhou, Peoples R China
[3] Guizhou Univ, Guizhou Prov Peoples Hosp, Med Coll, Dept Pediat, Guiyang, Guizhou, Peoples R China
[4] Fudan Univ, Childrens Hosp, Dept Neurol, Shanghai 2001102, Peoples R China
[5] Shanghai Jiao Tong Univ, Shanghai Childrens Med Ctr, Sch Med, Dept Neurol Rehabil,Guizhou Branch, Guiyang 550081, Guizhou, Peoples R China
基金
中国国家自然科学基金;
关键词
Autism spectrum disorder; Digital interventions; Meta-analysis; Robotic interventions; RANDOMIZED CONTROLLED-TRIAL; HIGH-FUNCTIONING CHILDREN; BEHAVIORAL INTERVENTION; PSYCHOSOCIAL TREATMENT; EFFICACY; INDIVIDUALS; COMPONENT; EMOTIONS; PROGRAM; ADULTS;
D O I
10.1002/ped4.12417
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
ImportanceDigital technology is now widely available for the interventions of autism, but its validity and feasibility remain to be proved.ObjectiveThis study aimed to investigate the effectiveness of digital health interventions (DHIs) in improving core symptoms or intelligence quotient in patients with autism spectrum disorder (ASD).MethodsThree databases including PubMed, Cochrane, and Scopus, were searched on November 15, 2022. Randomized clinical trials that enrolled patients with ASD who received DHIs and a control group without DHI treatment were included. Cochrane risk of bias tool (RoB 2) was applied to assess the risk of bias.ResultsA total of 33 studies, involving 1285 participants (658 [51.2%] in DHI groups and 627 [48.8%] in control groups), were analyzed to investigate the differences between DHI groups and control groups. Significantly greater improvements in the overall performance of ASD were observed in the DHI groups compared to the control groups (including active, waitlist, treatment-as-usual, and no treatment) with an effect size of 1.89 (Cohen's d 95% confidence interval [CI]: 1.26-2.52). Studies with treatment-as-usual, waitlist, and no treatment control demonstrated large effect sizes of Cohen's d 3.41 (95% CI: 0.84-5.97), Cohen's d 4.27 (95% CI: 1.95-6.59), and Cohen's d 4.52 (95% CI: 2.98-6.06) respectively. In contrast, studies with active control revealed insignificant effect sizes (Cohen's d 0.73, 95% CI: 0.12-1.33).InterpretationThis meta-analysis found significantly greater improvements in core symptoms or intelligence quotient in ASD patients receiving DHIs compared to those in control conditions. ASD patients may benefit from the DHIs and reduce the economic burden. This meta-analysis found significantly greater improvements in core symptoms or intelligence quotient in patients with autism spectrum disorder receiving digital health interventions compared to those in control conditions. Patients with autism spectrum disorder may benefit from digital health interventions and reduce the economic burden. * image
引用
收藏
页码:224 / 236
页数:13
相关论文
共 50 条
  • [1] Digital interventions for autism spectrum disorders: A systematic review and meta-analysis
    Wang Tianqi
    Ma Yu
    Du Xiaonan
    Li Chunpei
    Peng Zhongbi
    Wang Yi
    Zhou Hao
    [J]. 儿科学研究(英文)., 2024, 08 (03)
  • [2] The Efficacy of Early Interventions for Children with Autism Spectrum Disorders: A Systematic Review and Meta-Analysis
    Daniolou, Sofia
    Pandis, Nikolaos
    Znoj, Hansjoerg
    [J]. JOURNAL OF CLINICAL MEDICINE, 2022, 11 (17)
  • [3] Catatonia in autism spectrum disorders: A systematic review and meta-analysis
    Vaquerizo-Serrano, J.
    Salazar De Pablo, G.
    Singh, J.
    Santosh, P.
    [J]. EUROPEAN PSYCHIATRY, 2021, 65 (01)
  • [4] Melatonin in autism spectrum disorders: a systematic review and meta-analysis
    Rossignol, Daniel A.
    Frye, Richard E.
    [J]. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2011, 53 (09): : 783 - 792
  • [5] Antioxidant interventions in autism spectrum disorders: A meta-analysis
    Liu, Yiying
    Yang, Zimeng
    Du, Yang
    Shi, Sha
    Cheng, Yong
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2022, 113
  • [6] Digital Interventions for Autism Spectrum Disorder: A Meta-analysis
    Sandgreen, Helena
    Frederiksen, Line Hofmann
    Bilenberg, Niels
    [J]. JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, 2021, 51 (09) : 3138 - 3152
  • [7] Digital Interventions for Autism Spectrum Disorder: A Meta-analysis
    Helena Sandgreen
    Line Hofmann Frederiksen
    Niels Bilenberg
    [J]. Journal of Autism and Developmental Disorders, 2021, 51 : 3138 - 3152
  • [8] Prevalence of epilepsy in autism spectrum disorders: A systematic review and meta-analysis
    Liu, Xian
    Sun, Xin
    Sun, Caihong
    Zou, Mingyang
    Chen, Yiru
    Huang, Junping
    Wu, Lijie
    Chen, Wen-Xiong
    [J]. AUTISM, 2022, 26 (01) : 33 - 50
  • [9] A systematic review and meta-analysis of the fMRI investigation of autism spectrum disorders
    Philip, Ruth C. M.
    Dauvermann, Maria R.
    Whalley, Heather C.
    Baynham, Katie
    Lawrie, Stephen M.
    Stanfield, Andrew C.
    [J]. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2012, 36 (02): : 901 - 942
  • [10] Androgen levels in autism spectrum disorders: a systematic review and meta-analysis
    Wang, Zhao
    Zhang, Bohan
    Mu, Chenyu
    Qiao, Dan
    Chen, Huan
    Zhao, Yan
    Cui, Huixian
    Zhang, Rong
    Li, Sha
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2024, 15